0000899243-21-000918.txt : 20210107 0000899243-21-000918.hdr.sgml : 20210107 20210107180101 ACCESSION NUMBER: 0000899243-21-000918 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hyare Parvinder S CENTRAL INDEX KEY: 0001838253 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 21515073 MAIL ADDRESS: STREET 1: SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-01-01 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001838253 Hyare Parvinder S SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 960 D Stock Option (Right to Buy) 61.80 2025-11-30 Common Stock 2400 D Stock Option (Right to Buy) 40.00 2026-11-30 Common Stock 3500 D Stock Option (Right to Buy) 26.20 2024-07-10 Common Stock 2695 D Stock Option (Right to Buy) 36.90 2027-12-29 Common Stock 6999 D Stock Option (Right to Buy) 4.16 2028-12-31 Common Stock 6999 D Stock Option (Right to Buy) 12.15 2029-03-29 Common Stock 2749 D Stock Option (Right to Buy) 8.60 2029-07-31 Common Stock 749 D Stock Option (Right to Buy) 4.15 2030-03-31 Common Stock 28499 D Fully vested. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of December 29, 2017. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of December 31, 2018. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 29, 2019. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of July 31, 2019. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months. Interim Chief Executive Officer /s/ Parvinder S. Hyare 2021-01-07